Sutro Biopharma Inc. Com SHSSTRO
13F holders, Q2 2026 (June 30)3holders −4
0new positions
3sold out
$33.20avg. 13F price*
At the end of Q2 2026, 3 institutions reported holding Sutro Biopharma Inc. Com SHS (STRO) in their 13F filings, down 4 from Q1 2026. 0 opened new positions and 3 sold out. The largest holders were Fortitude Family Office, LLC ($2K), Bogart Wealth, LLC ($2K) and Parallel Advisors, LLC ($2K).
- Company
- Sutro Biopharma Inc. Com SHS
- CUSIP
- 869367102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $6.8M |
All 13F filers, Q1 2026 → Q2 2026: 272,385 shares sold, net −272,385 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Fortitude Family Office, LLC | 0.00% | No change | 56 | $2K |
| Bogart Wealth, LLC | 0.00% | No change | 50 | $2K |
| Parallel Advisors, LLC | 0.00% | No change | 47 | $2K |
"% of holder's portfolio" is STRO's weight in each manager's 13F, not the share of Sutro Biopharma Inc. Com SHS the manager owns.